DACVCP logo
Focused certification exam prep
Start practice

DACVCP Meaning

TL;DR
  • DACVCP means Diplomate, American College of Veterinary Clinical Pharmacology, a veterinary specialty credential governed by the ACVCP.
  • Earning the title requires passing both Phase I (200 multiple-choice questions) and Phase II (ten question groups worth 200 points).
  • Phase II eligibility requires two peer-reviewed papers accepted or published by February 1 of the examination year.
  • Both phases must be passed within a five-year eligibility window; this is an exam window, not a renewal cycle.

What the Letters Stand For

DACVCP stands for Diplomate, American College of Veterinary Clinical Pharmacology. Each piece of the acronym carries meaning. "Diplomate" is the formal term for a veterinarian who has been certified by a specialty college. "American College of Veterinary Clinical Pharmacology" is the certifying organization, usually shortened to ACVCP. When you see the letters after a veterinarian's name, they signal that the person completed approved residency-level training in clinical pharmacology and passed a two-phase credentialing process administered by that college.

This page is about that specific credential. Other pharmacology-adjacent designations in other professions can look similar on a résumé, but the Diplomate credential discussed here belongs to the veterinary specialty college and is tied to veterinary drug science: how drugs behave in animals, why they fail, how to dose them, and how to evaluate them. If you want the short-form definitions, our companion pages cover what DACVCP stands for and what DACVCP is, while this article goes deeper into what the credential demands.

The College Behind the Credential

The ACVCP is the governing and administering body for the credential. It publishes the application timelines, fee schedules, residency pathways and examination pages that define how a candidate becomes a Diplomate. It also maintains a Maintenance of Certification committee that administers recertification for existing Diplomates.

A note on what is and is not publicly settled: historical bylaws text (approved June 2018) describes review of maintenance records every two years toward maintenance at ten years, but the complete legacy file could not be retrieved in the latest check, and the detailed committee page requires authorization. Current renewal hours, fees and intervals should therefore be confirmed directly with the college rather than assumed from older documents.

Why the source matters: Certification details change. Phase I and Phase II blueprints were last revised in December 2021 in their indexed legacy form, and the current blueprint downloads could not be retrieved during verification. Treat any outline you find, including the domain list below, as preparation guidance and confirm the current scope with the ACVCP before committing study hours.

What a Diplomate Is Expected to Know

The title implies mastery of a broad pharmacology curriculum. The dated Phase I preparation headings run from basic science through organ-system pharmacology and drug classes. The Phase II examination page lists four subject categories. Together they form the 26 headings used on this site (a count of supplied headings, not an official combined domain count). For the full walkthrough, see our complete guide to all 26 DACVCP content areas.

Foundational science (legacy Phase I headings)

Domains 1-9: Principles of Drug Behavior

These headings cover how a molecule is built, how it moves, what it does, and why therapy goes wrong.

  • Physiochemical characteristics of active pharmaceutical ingredients (the source spelling)
  • Pharmacodynamics and drug movement
  • Pharmacokinetics
  • Factors impacting drug movement and/or drug response
  • Routes of administration
  • Dosing forms (and relevant drug delivery devices)
  • Adverse events
  • Causes for therapeutic failure

Organ systems and drug classes

Domains 10-22: Applied Pharmacology by System and Class

These headings apply the principles to body systems and therapeutic categories.

  • Nervous system, renal, cardiovascular, gastrointestinal, reproduction, endocrine
  • General and special senses
  • Control of inflammation/immunomodulation
  • Anticancer drugs and fluid therapy
  • Anti-infectives
  • Botanical/herbals
  • Disinfectants/antiseptics

Phase II subject categories

Domains 23-26: The Four Phase II Categories

The current Phase II page names four categories. It does not publish current category percentages, so none are stated here.

  • Therapeutics
  • Pharmacokinetics and Therapeutic Drug Monitoring
  • Experimental Design, Statistics and Analytical Methods
  • Regulatory Pharmacology

Notice the shift: Phase I leans toward broad pharmacology knowledge, while Phase II pushes into applied therapeutics, quantitative reasoning, trial design and regulatory thinking. A Diplomate is expected to operate comfortably in both modes.

The Two-Phase Path to the Title

The complete credential requires both phases. They are sequential, and each has its own eligibility gate.

ElementPhase IPhase II
PrerequisiteLegally qualified to practice veterinary medicine; enrolled in or completed approved ACVCP residency training; two referencesCompleted approved training, Phase I pass, approved credentials, course documentation and transcripts, two qualifying papers
Exam structure200 multiple-choice questions in two 100-question sessionsTen question groups worth 200 points across two 100-point sessions
Question stylesMultiple choiceWritten responses, multiple choice, fill-in-the-blank and extended matching
Active exam timeEight hours, excluding breakEight hours under the ordinary schedule

One caution: Phase II's 200 points are not a 200-question count. The ten groups mix question formats, and points are allocated across them. For the eligibility details behind each gate, see our DACVCP requirements guide.

The Phase II publication requirement

This is the feature that most distinguishes the credential from many other certifications. Phase II candidates must have two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research; the other may be original research or an eligible evidence-based systematic review or meta-analysis. First authorship is required on at least one paper. Neither paper may have been used for another specialty board, and publication must not predate the beginning of training by more than two years.

Plan the papers early: Because publication timing is tied to a February 1 deadline and the training start date, the research pipeline effectively starts years before the exam. A candidate who treats Phase II as only an exam problem may discover too late that the credentials file is the real bottleneck.

Exam Format and Remote Delivery

The published 2026 administration was delivered remotely using ExamSoft: Phase I on May 19 and Phase II on June 30. Those dates have passed, and a 2027 schedule was not verified, so check the college's Candidate Information page for the next cycle. For the date-and-deadline picture, see our DACVCP exam dates guide.

Practical delivery details from the published materials:

  • Candidates supply a compatible Windows or Mac laptop running Examplify, with administrator privileges.
  • Encrypted examinations are downloaded in advance and unlocked with a proctor password.
  • Examination mode blocks internet access, files and other applications.
  • Phase I ordinarily runs 08:00-12:00 and 14:00-18:00 local time, in two 100-question sessions.
  • Advance practice examinations are available to rehearse the software and become familiar with question structure.

The dated 2026 notice takes precedence over generic phase-page references to a testing location or on-site practice, so do not assume an in-person site without confirming the current cycle.

Fees and Registration Mechanics

The published 2026 cycle lists these charges:

StepPublished 2026 Amount
Phase I applicationUSD 75
Phase I examinationUSD 200
Phase II credentials reviewUSD 250
Phase II examinationUSD 300

Two details deserve care. First, a separate residency-information page calls USD 75 a first-year candidate registration fee. The public pages do not establish whether that is the same charge as the Phase I application fee or an additional one, so do not assume either; ask the college. Second, retakes require the respective examination fee. The general fee page permits refunds only for extenuating circumstances accepted by the Board, while the phase pages describe examination fees as nonrefundable. For a fuller budget view, including costs beyond these published fees, see our DACVCP certification cost breakdown.

Deadlines on the Phase II side

Applications are ordinarily due October 1 before the examination year, with intent to sit due by February 1. The currently dated checklist covers October 1, 2025 and February 1, 2026. Because the paper-acceptance cutoff is also February 1, those two obligations land on the same date.

The Five-Year Eligibility Window

Both phases must be passed within a five-year eligibility period. The period begins with the first eligible examination year after Phase I approval. The issuer's own example: approval in December 2025 permits examinations from 2026 through 2030.

Key Takeaway

The five-year window is an examination eligibility limit, not credential renewal. Do not confuse it with maintenance of certification, which is a separate process administered by a dedicated committee after you become a Diplomate.

This window shapes strategy. Because Phase II depends on a Phase I pass, delays in passing Phase I or in assembling papers consume the same five-year clock.

Where Diplomates Work

The public materials do not publish a hiring survey, so employer distribution should not be quantified. Qualitatively, the skill set maps to settings where drug behavior, dosing evidence and regulatory knowledge matter:

  • Academic veterinary programs: teaching pharmacology, supervising residents and running research programs.
  • Clinical pharmacology services: supporting dosing, therapeutic drug monitoring and adverse event questions for clinicians.
  • Industry: drug development, formulation and study design roles where pharmacokinetics and trial methods are central.
  • Regulatory and government settings: roles touching regulatory pharmacology and product evaluation.

For career-oriented detail, see our pages on DACVCP jobs and DACVCP earnings, and for the bigger decision, whether the certification is worth it.

Sequencing Preparation Around the Domains

Generic study methods matter less here than domain order. Because the foundational headings (Domains 1-9) underpin everything else, they belong first. Pharmacokinetics and drug movement in particular recur across system chapters, so calculation fluency pays off repeatedly.

Weeks 1-3

Principles first

  • Physiochemical properties, drug movement and pharmacokinetics (Domains 1, 3, 4)
  • Pharmacodynamics and factors altering response (Domains 2, 5)
Weeks 4-6

Delivery and failure modes

  • Routes of administration and dosing forms (Domains 6, 7)
  • Adverse events and causes for therapeutic failure (Domains 8, 9)
Weeks 7-10

Systems and classes

  • Organ-system chapters (Domains 10-16)
  • Inflammation, anticancer, fluids, anti-infectives, botanicals, antiseptics (Domains 17-22)
Phase II prep

Applied and quantitative

  • Therapeutics and therapeutic drug monitoring (Domains 23, 24)
  • Experimental design, statistics and regulatory pharmacology (Domains 25, 26)

Treat this as a skeleton, not a prescription; your residency training and the current blueprint should refine it. For a full plan, use our DACVCP study guide, and for a condensed refresher, the DACVCP cheat sheet. When you want exam-style repetition, our practice test platform offers question drills to build speed with multiple-choice formats.

Preparing for the written-response style

Phase I is entirely multiple choice, but Phase II adds written responses and extended matching. Candidates who have only drilled recognition-style questions should practice composing short, structured answers: state the mechanism, justify the dose logic, name the monitoring plan and flag the adverse event risk. Because the Phase II format mixes question types across ten groups, versatility counts.

Keeping the Acronym Straight

Searching for "DACVCP meaning" can surface material about unrelated credentials that happen to share the same letters. Everything on this page refers only to the veterinary clinical pharmacology Diplomate credential from the ACVCP. If a source mentions a different certifying body, different fee schedule or a different exam structure, it is describing something else.

When verifying any claim, check it against the ACVCP's own pages: the Phase I and Phase II examination pages, Candidate Deadlines and Fees, Candidate Information and the Phase II Credentials Review. Related definition pages on this site include what DACVCP means, what DACVCP certification is and the credential overview. If you are weighing difficulty, see how hard the exam is; for scoring, note that a fixed numerical pass mark and current pass rate were not verified, which is covered on our passing score and pass rate pages.

What does DACVCP stand for?

DACVCP stands for Diplomate, American College of Veterinary Clinical Pharmacology. It identifies a veterinarian certified by the ACVCP in the specialty of veterinary clinical pharmacology.

Does the DACVCP credential require passing more than one exam?

Yes. The complete credential requires both Phase I and Phase II. Phase I is 200 multiple-choice questions; Phase II has ten question groups worth 200 points, using written responses, multiple choice, fill-in-the-blank and extended matching.

What publication requirement applies to Phase II?

Candidates need two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research, and at least one must have the candidate as first author. Neither may have been used for another specialty board.

How long do I have to pass both phases?

Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. The issuer's example is approval in December 2025 permitting 2026-2030 examinations. This is an exam window, not renewal.

Is the DACVCP exam taken in person?

The published 2026 administration was remote using ExamSoft, with Phase I on May 19 and Phase II on June 30. Those dates have passed and a 2027 schedule was not verified, so confirm delivery arrangements with the ACVCP before planning travel.

Ready to pass your DACVCP exam?

Put this into practice with free DACVCP questions across every exam domain.